DOX
$68.90
Amdocs Ltd Ord
($.07)
(.10%)
Earnings Details
2nd Quarter March 2018
Thursday, May 10, 2018 4:01:00 PM
Tweet Share Watch
Summary

Amdocs, Ltd.

Amdocs Ltd Ord (DOX) reported 2nd Quarter March 2018 earnings of $0.88 per share on revenue of $992.3 million. The consensus earnings estimate was $0.89 per share on revenue of $980.6 million. Revenue grew 2.7% on a year-over-year basis.

The company said it expects third quarter non-GAAP earnings of $1.00 to $1.06 per share on revenue of $990.0 million to $1.03 billion. The current consensus earnings estimate is $1.00 per share on revenue of $992.7 million for the quarter ending June 30, 2018.

Amdocs Ltd is a provider of software products and services to the communications, media and entertainment industry. It provides software and services solutions in North America and Europe.

Results
Reported Earnings
$0.88
Earnings Whisper
-
Consensus Estimate
$0.89
Reported Revenue
$992.3 Mil
Revenue Estimate
$980.6 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Amdocs Limited Reports Second Quarter Fiscal 2018 Results Record Quarterly Revenue of $992M

Expects Fiscal 2018 GAAP Diluted EPS Growth Outlook of 0.0%-6.0% YoY

Reiterates Fiscal 2018 Non-GAAP Diluted EPS Growth Outlook of 4.0%-8.0% YoY 

Second Quarter Fiscal 2018 Highlights

  • Closed the previously announced acquisition of Vubiquity for $224 million in cash and acquired UXP Systems for $80 million in cash
  • Revenue of $992 million, within the $960-$1,000 million guidance range; revenue included a positive impact from foreign currency movements relative to the first quarter of fiscal 2018, and contributions from M&A  consummated this quarter
  • GAAP diluted EPS of $0.70, above the midpoint of the $0.65-$0.73 guidance range
  • Non-GAAP diluted EPS of $0.95, above the midpoint of the $0.91-$0.97 guidance range
  • GAAP operating income of $132 million; GAAP operating margin of 13.3%
  • Non-GAAP operating income of $172 million; non-GAAP operating margin of 17.3%
  • Free cash flow of $3 million, comprised of cash flow from operations of $114 million, less $111 million in net capital expenditures and other, of which $81 million related to the multi-year development of the new campus. Excluding the campus investment, normalized free cash flow was $84 million in the second quarter of fiscal 2018
  • Twelve-month backlog of $3.32 billion, up $60 million sequentially
  • Quarterly cash dividend of $0.25 per share, to be paid on July 20, 2018

ST. LOUIS, May 10, 2018 (GLOBE NEWSWIRE) -- Amdocs Limited (NASDAQ:DOX) today reported operating results for the three months ended March 31, 2018.

“We are pleased to report solid results for our second fiscal quarter which included double-digit growth in Europe and record revenue in Rest of World. Our operating profitability was stable and we grew our 12-month backlog to another new high. Additionally, we extended our technology leadership with the launch of AmdocsOne at Mobile World Congress and we utilized our cash to close on the acquisitions of Vubiquity, as well as UXP Systems, a leader in User Lifecycle Management solutions,” said Eli Gelman, president and chief executive officer of Amdocs Management Limited.

Gelman continued, “Rest of World was a highlight of the quarter as we focused on project execution and securing new awards. In Southeast Asia, we commenced the ramp-up of the seven-year project and managed services agreement we signed with PLDT earlier in Q2. Additionally, we made an important step in Africa where we were selected to provide our revenue assurance capabilities to Safaricom, a major mobile network operator in Kenya with nearly 30 million subscribers.”

Gelman concluded, “We enter Q3 on-track to deliver a stronger second half, although we are of course monitoring the many moving parts affecting our outlook, including those resulting from consolidation activity currently in progress across our main operating regions. Additionally, we are focused on our execution and profitability, which combined with expected normalized free cash flow generation of approximately $500 million for the full year, leaves us well positioned to deliver diluted non-GAAP earnings per share growth in the range of 4% to 8% in fiscal 2018.”

Revenue

  • Revenue for the second fiscal quarter ended March 31, 2018 was $992.3 million, up 1.5% or $14.6 million sequentially from the first fiscal quarter of 2018 and up 2.7% as compared to last year’s second fiscal quarter. Revenue for the second fiscal quarter of 2018 includes a positive impact from foreign currency movements of approximately $5 million relative to the first quarter of fiscal 2018 and contributions from M&A consummated in the second fiscal quarter. 

Net Income and Earnings Per Share

The Company's GAAP net income for the second quarter of fiscal 2018 was $101.7 million, or $0.70 per diluted share, compared to GAAP net income of $112.6 million, or $0.76 per diluted share, in the prior fiscal year’s second quarter. Net income on a non-GAAP basis was $137.4 million, or $0.95 per diluted share, compared to non-GAAP net income of $139.2 million, or $0.94 per diluted share, in the second quarter of fiscal 2017.

Returning Cash to Shareholders

  • Quarterly Cash Dividend Program: On May 10, 2018, the Board approved the Company’s next quarterly cash dividend payment of $0.25 per share and set June 29, 2018 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on July 20, 2018.
  • Share Repurchase Activity: Repurchased $120 million of ordinary shares during the second quarter of fiscal 2018.

Twelve-month Backlog
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.32 billion at the end of the second quarter of fiscal 2018, up $60 million from the end of the prior quarter.

Third Quarter Fiscal 2018 Outlook

  • Revenue of approximately $990-$1,030 million, including an immaterial sequential impact from foreign currency fluctuations as compared to the second quarter of fiscal 2018. Third quarter fiscal 2018 guidance incorporates full quarter contributions from recently closed acquisitions
  • Diluted GAAP EPS of approximately $0.71-$0.81. The impact on diluted GAAP EPS of the acquisition of Vubiquity and UXP Systems is subject to finalization of the purchase price allocation and of the anticipated acquisition-related expenses related to operating adjustments, restructuring charges and other acquisition-related costs.
  • Diluted non-GAAP EPS of approximately $1.00-$1.06, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.07 per share of equity-based compensation expense, net of related tax effects. Expected non-GAAP effective tax rate around the low-end of the annual target range of 13%-17% in the third quarter fiscal 2018

Full Year Fiscal 2018 Outlook

  • Expects revenue growth of 2.3%-4.3% year-over-year as reported compared with previous guidance of 0.0%-4.0% year-over-year
  • Expects revenue growth of 1.3%-3.3% year-over-year on a constant currency basis compared with previous guidance of (1.0%)-3.0% year-over-year
  • Full year fiscal 2018 revenue guidance incorporates an incremental revenue contribution of more than 1% from Vubiquity on both a constant currency and reported basis, and an expected positive impact from foreign currency fluctuations of about 1% year-over-year
  • Expects GAAP diluted earnings per share growth of roughly 0.0%-6.0% year-over-year. The impact on diluted GAAP EPS of the acquisition of Vubiquity and UXP Systems is subject to finalization of the purchase price allocation and of the anticipated expenses related to operating adjustments, restructuring charges and other acquisition-related costs
  • Reiterates Non-GAAP diluted earnings per share growth of roughly 4.0%-8.0% year-over-year, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.26-$0.29 per share of equity-based compensation expense, net of related tax effects. Expected non-GAAP effective tax rate to remain within the same target range of 13%-17% for the full year fiscal 2018
  • The impact of recent acquisitions on Amdocs’ diluted non-GAAP earnings per share (excluding amortization of purchased intangible assets, restructuring charges, other acquisition-related costs and equity based compensation expense, net of related tax effects) is expected to be neutral in fiscal year 2018, and accretive thereafter

Our third fiscal quarter 2018 and full year fiscal 2018 outlook takes into consideration the Company’s expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, Amdocs notes market dynamics continue to shift rapidly and that it cannot predict all possible outcomes, including those resulting from AT&T’s proposed merger with Time Warner, T-Mobile’s proposed merger with Sprint, or from other current and potential customer consolidation activity in North America. 

Conference Call Details
Amdocs will host a conference call on May 10, 2018 at 5:00 p.m. Eastern Time to discuss the Company's second quarter of fiscal 2018 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 4175387. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com

Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets and other acquisition-related costs;
  • changes in fair value of certain acquisition-related liabilities;
  • nonrecurring restructuring charges;
  • equity-based compensation expense; and
  • tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

About Amdocs
Amdocs is a leading software and services provider to the world’s most successful communications and media companies. As our customers reinvent themselves, we enable their digital and network transformation through innovative solutions, delivery expertise and intelligent operations. Amdocs and its 25,000 employees serve customers in over 85 countries. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $3.9 billion in fiscal 2017.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2017 filed on December 11, 2017 and our Form 6-K furnished for the first quarter of fiscal 2018 on February 12, 2018.

Contact:
Matthew Smith
Head of Investor Relations
Amdocs 314-212-8328
E-mail: dox_info@amdocs.com

                                             

 
 
AMDOCS LIMITED
 
Consolidated Statements of Income
(in thousands, except per share data)
 
  Three months ended  Six months ended
  March 31, March 31,
  2018 2017 2018 2017
             
Revenue $992,340 $966,009 $1,970,051 $1,920,736
             
Operating expenses:            
Cost of revenue  646,587  621,737  1,289,784  1,242,571
Research and development  64,926  67,303  133,103  127,293
Selling, general and administrative  120,199  114,465  238,867  238,544
Amortization of purchased intangible assets and other  28,801  28,723  54,327  56,954
   860,513  832,228  1,716,081  1,665,362
Operating income  131,827  133,781  253,970  255,374
             
Interest and other expense, net  239  468  118  3,231
Income before income taxes  131,588  133,313  253,852  252,143
             
Income taxes  29,861  20,753  35,252  41,790
Net income $101,727 $112,560 $218,600 $210,353
Basic earnings per share $0.71 $0.77 $1.52 $1.43
Diluted earnings per share $0.70 $0.76 $1.51 $1.42
Basic weighted average number of shares outstanding  143,030  146,595  143,487  146,706
Diluted weighted average number of shares outstanding  144,390  147,954  144,882  148,168
Cash dividends declared per share $0.250 $0.220 $0.470 $0.415
             
             


AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
 
  Three months ended  Six months ended
  March 31, March 31,
   2018  2017  2018  2017
             
Revenue $992,340 $966,009 $1,970,051 $1,920,736
             
Non-GAAP operating income  171,760  165,997  340,824  330,082
             
Non-GAAP net income  137,350  139,164  291,816  272,731
             
Non-GAAP diluted earnings per share $0.95 $0.94 $2.01 $1.84
             
Diluted weighted average number of shares outstanding  144,390  147,954  144,882  148,168
             
             


AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
 (in thousands)
 
   Three months ended
  March 31, 2018
  
  Reconciliation items 
 GAAP Amortization of
purchased
intangible assets
and other
Equity based
compensation
expense
Changes in fair
value of certain
acquisition-
related liabilities
Tax effectNon-GAAP
Operating expenses:                
Cost of revenue$646,587$- $(4,727)$(574)$- $641,286
Research and
 development
 64,926 -  (769) -  -  64,157
Selling, general and 
 administrative
 120,199 -  (5,062) -  -  115,137
Amortization of
 purchased
 intangible assets
 and other
 28,801 (28,801) -  -  -  -
Total operating expenses 860,513 (28,801) (10,558) (574) -  820,580
                 
Operating income 131,827 28,801  10,558  574  -  171,760
                 
Income taxes 29,861 -  -  -  4,310  34,171
                 
Net income$101,727$28,801 $10,558 $574 $(4,310)$137,350
                 
                 
 
 
 
 
  Three months ended
  March 31, 2017
  
  Reconciliation items 
 GAAPAmortization of
purchased
intangible assets
and other
Equity based
compensation
expense

Changes in fair
value of certain
acquisition-
related liabilities
Tax effect

 
Non-GAAP
Operating expenses:      
Cost of revenue$621,737$- $(4,973)$6,691 $- $623,455
Research and
 development
 67,303 -  (901) -  -  66,402
Selling, general and 
 administrative
 114,465 -  (4,310) -  -  110,155
Amortization of
 purchased
 intangible assets
 and other
 28,723 (28,723) -  -  -  -
Total operating expenses 832,228 (28,723) (10,184) 6,691  -  800,012
                 
Operating income 133,781 28,723  10,184  (6,691) -  165,997
                 
Income taxes 20,753 -  -  -  5,612  26,365
                 
Net income$112,560$28,723 $10,184 $(6,691)$(5,612)$139,164
                 
                 


AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
 (in thousands)
 
   Six months ended
March 31, 2018
  
  Reconciliation items 
 GAAPAmortization
of purchased
intangible
assets and other
Equity based
compensation
expense
Changes in fair
value of certain
acquisition-
related
liabilities
Tax effect

 
One-time
tax benefit
relating to
the new
U.S. tax
legislation
Non-GAAP
Operating expenses:       
Cost of revenue$1,289,784$- $(9,425)$(8,464)$- $- $1,271,895
Research and
  development
 133,103 -  (1,593) -     -  131,510
Selling, general and 
 administrative
 238,867 -  (13,045) -     -  225,822
Amortization of
 purchased
 intangible assets
 and other
 54,327 (54,327) -  -     -  -
Total operating expenses 1,716,081 (54,327) (24,063) (8,464)    -  1,629,227
                    
Operating income 253,970 54,327  24,063  8,464     -  340,824
                    
Income taxes 35,252 -  -  -  10,688  2,950  48,890
                    
Net income$218,600$54,327 $24,063 $8,464 $(10,688)$(2,950)$291,816
                    
                    


   Six months ended
  March 31, 2017
  
  Reconciliation items 
 GAAPAmortization
of purchased
intangible
assets and
other
Equity based
compensation
expense
Changes in fair
value of certain
acquisition-
related
liabilities
Tax effect

 
Non-GAAP
Operating expenses:      
Cost of revenue$1,242,571$- $(9,971)$6,691 $- $1,239,291
Research and
  development
 127,293 -  (1,800) -  -  125,493
Selling, general and 
  administrative
 238,544 -  (12,674) -  -  225,870
Amortization of
  purchased
  intangible assets
  and other
 56,954 (56,954) -  -  -  -
Total operating expenses 1,665,362 (56,954) (24,445) 6,691  -  1,590,654
                 
Operating income 255,374 56,954  24,445  (6,691) -  330,082
                 
Income taxes 41,790 -  -  -  12,330  54,120
                 
Net income$210,353$56,954 $24,445 $(6,691)$(12,330)$272,731
                 
                 


AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
 
 As of
  March 31,
2018
 September 30
2017
       
ASSETS      
       
Current assets      
Cash, cash equivalents and short-term interest-bearing investments $666,843 $979,608
Accounts receivable, net, including unbilled of $249,377 and $229,695, respectively  972,279  865,068
Prepaid expenses and other current assets  221,825  203,810
Total current assets  1,860,947  2,048,486
       
Property and equipment, net  471,818  355,685
Goodwill and other intangible assets, net  2,780,956  2,398,535
Other noncurrent assets  465,270  476,674
Total assets $5,578,991 $5,279,380
       
LIABILITIES AND EQUITY      
       
Current liabilities      
       
Accounts payable, accruals and other $1,141,799 $1,059,855
Short-term financing arrangements  120,000  -
Deferred revenue  128,556  113,091
Total current liabilities  1,390,355  1,172,946
Other noncurrent liabilities  582,419  532,364
Total Amdocs Limited Shareholders’ equity  3,563,054  3,574,070
Noncontrolling interests  43,163  -
Total equity $3,606,217 $3,574,070
Total liabilities and equity $5,578,991 $5,279,380
       
       


AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
 
  Six months ended March 31,
  2018 2017
         
Cash Flow from Operating Activities:        
Net income $218,600  $210,353 
Reconciliation of net income to net cash provided by operating activities:        
Depreciation and amortization  102,900   109,038 
Equity-based compensation expense  24,063   24,445 
Deferred income taxes  (3,584)  16,889 
Excess tax benefit from equity-based compensation  -   (2,929)
loss (Gain)  from short-term interest-bearing investments  1,195   (17)
Net changes in operating assets and liabilities, net of amounts acquired:        
Accounts receivable, net  (77,359)  (25,092)
Prepaid expenses and other current assets  (9,509)  (10,926)
Other noncurrent assets  (10,606)  (42,294)
Accounts payable, accrued expenses and accrued personnel  23,103   25,101 
Deferred revenue  8,600   (19,932)
Income taxes payable, net  8,675   (8,813)
Other noncurrent liabilities  (7,749)  (469)
Net cash provided by operating activities  278,329   275,354 
         
Cash Flow from Investing Activities:        
Purchase of property and equipment  (162,126)  (69,906)
Proceeds from sale of short-term interest-bearing investments  207,738   144,920 
Purchase of short-term interest-bearing investments  (76,037)  (145,737)
Net cash paid for acquisitions  (352,599)  - 
Other  (3,446)  1,671 
Net cash used in investing activities  (386,470)  (69,052)
         
Cash Flow from Financing Activities:        
Borrowings under financing arrangements  120,000   200,000 
Payments under financing arrangements  -   (200,000)
Repurchase of shares  (239,779)  (160,232)
Investment by noncontrolling interest, net  47,013   - 
Proceeds from employee stock options exercised  65,631   62,368 
Payments of dividends  (63,294)  (57,299)
Excess tax benefit from equity-based compensation and other  (110)  2,929 
Net cash used in financing activities  (70,539)  (152,234)
         
Net (decrease) increase in cash and cash equivalents  (178,680)  54,068 
Cash and cash equivalents at beginning of period  649,611   768,660 
Cash and cash equivalents at end of period $470,931  $822,728 
         
         



AMDOCS LIMITED
Supplementary Information
 (In millions)
                
  Three months ended
  March 31,
 2018
 December 31,
2017
 September 30,
2017
 June 30,
2017
 March 31,
 2017
North America $624.2 $643.0 $644.1 $637.9 $636.3
Europe  148.6  133.7  129.8  125.2  115.4
Rest of World  219.5  201.0  205.8  203.6  214.3
Total Revenue $992.3 $977.7 $979.7 $966.7 $966.0
                


  Three months ended
  March 31,
 2018
 December 31,
2017
 September 30,
2017
 June 30,
2017
 March 31,
 2017
Managed Services Revenue $  508.9 $  518.7 $  503.8 $  496.3 $  511.1
                


  Three months ended
  March 31,
2018
 December 31,
2017
 September 30,
2017
 June 30,
2017
 March 31,
2017
Customer Experience
Solutions 
 $980.7 $965.9 $967.7  $954.8  $948.6
Directory  11.6  11.8  12.0  11.9  17.4
Total Revenue $  992.3 $  977.7 $  979.7 $  966.7 $  966.0
                


  As of
  March 31,
2018
 December 31,
2017
 September 30,
2017
 June 30,
2017
 March 31,
2017
12-Month Backlog $  3,320 $  3,260 $  3,250 $  3,220 $  3,210

Primary Logo

Source: Amdocs Management LTD